Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Reception and Implementation of the Japanese Grant of over USD 4 million to 14 Governmental Hospitals

 
Caretaker Deputy Prime Minister and Health Minister Ghassan Hasbani met this morning at his office in Bir Hassan with the Japanese Ambassador H.E. Matahiro Yamaguchi to celebrate the completion of the project of USD 4.289.000 Japanese grant aimed at improving 14 government hospitals in Lebanon; in Beirut: Rafic Hariri University Hospital, In Mount-Lebanon: Siblin, Shahar Gharbi, Daher El Bachek and Bouwar, North Lebanon: El Qoubbeh, Halba, and Sir Danniyeh, Beqaa: Zahleh, Baalbeck, Hermel and Rachaya and in South Lebanon: Marjaoun and Hasbaya.

The meeting was followed by a press conference held by Hasbani and the Japanese Ambassador in the presence of directors of the government hospitals that received the Japanese grant.

Arbid

The advisor to the Minister of Public Health Dr. Bahij Arbid noted that the grant aims at “enhancing the quality of services provided in the government hospitals” as he thanked Minister Hasbani who formed a committee for soft loans and grants, the Japanese Embassy and the action team at the Ministry.

Yamaguchi

The Japanese ambassador stated that Lebanon is one of the best countries in the region as to health care services. However, the Lebanese health care sector is trying to cope with the increasing medical needs of the Lebanese citizens and refugees. For this reason, Japan decided to support the Lebanese Ministry of Public Health with an emergency grant amounting to USD 5 million in order to provide 14 government hospitals with Japanese advanced equipment.

Hasbani

Hasbani thanked Japan for “its interest in the Lebanese hospitalization sector”.

"Many more hospitals benefit and will benefit from other grants provided by the Kuwaiti fund for example, which will focus on improving and equipping the emergency departments, in addition to a part of the world bank grant that will be allocated to the government hospitals as part of the financial project we secured this year,” Hasbani noted.
    3
    ...
ATC Name B/G Ingredients Dosage Form Price
D03AX BEPANTHEN PLUS B Chlorhexidine HCl - 5mg/g, Dexpanthenol - 50mg/g Cream 319,835 L.L
N03AX23 BRIVIACT B Brivaracetam - 25mg 25mg Tablet, film coated 9,627,931 L.L
N03AX23 BRIVIACT B Brivaracetam - 50mg 50mg Tablet, film coated 9,627,931 L.L
N03AX23 BRIVIACT B Brivaracetam - 10mg/ml 10mg/ml Solution 10,314,804 L.L
C01BG11 BRINAVESS B Vernakalant - 20mg/ml 20mg/ml Injectable concentrate for solution 41,821,582 L.L
D06AX BANEOCIN B Neomycin sulfate - 5000IU/g, Bacitracin zinc - 250IU/g Ointment 173,356 L.L
D06AX BATRAMYCIN B Neomycin (sulfate) - 5000IU/g, Bacitracin - 250IU/g Ointment 249,955 L.L
B01AC24 BRILINTA B Ticagrelor - 90mg 90mg Tablet, film coated 5,544,694 L.L
B02BD02 BERIATE BioHuman Coagulation Factor VIII - 250IU 250IU Injectable lyophilised powder for solution+diluent 14,098,526 L.L
B02BD02 BERIATE BioHuman Coagulation Factor VIII - 500IU 500IU Injectable lyophilised powder for solution+diluent 28,437,886 L.L
B02BD02 BERIATE BioHuman Coagulation Factor VIII - 500IU 500IU Injectable lyophilised powder for solution+diluent L.L
L01FF04 BAVENCIO BioTech Avelumab - 200mg/10ml 200mg/10ml Injectable concentrate for solution 101,243,761 L.L
G03DA04 BIOGEST BioTech Progesterone, bio-identical - 200mg 200mg Pessary 1,804,780 L.L
H05AA02 BONTEO BioTech Teriparatide - 20mcg/dose 20mcg/dose 17,383,843 L.L
L01FG01 BEVACIREL BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable solution 49,744,595 L.L
L01FG01 BIVASTINA 400 BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable concentrate for solution 92,353,609 L.L
L01FG01 BIVASTINA 400 BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable concentrate for solution 53,111,763 L.L
G03DA04 BIOGEST BioTech Progesterone, bio-identical - 100mg/2ml 100mg/2ml Injectable solution 2,328,879 L.L
G03DA04 BIOGEST BioTech Progesterone, bio-identical - 400mg 400mg Pessary 1,083,137 L.L
L01FG01 BEVACIREL BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable solution 14,719,570 L.L
L01FG01 BIVASTINA 100 BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable concentrate for solution 22,840,337 L.L
L01FG01 BIVASTINA 100 BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable concentrate for solution 12,021,318 L.L
L01FX07 BLINCYTO BioTech Blinatumomab - 35mcg 35mcg Injectable lyophilised powder for solution+stabilizer 239,128,127 L.L
M03AX01 BOTOX BioTech Clostridium botulinum type A neurotoxin complex - 100U 100U Injectable powder for solution 18,625,995 L.L
M03AX01 BOTOX BioTech Clostridium botulinum type A neurotoxin complex - 100U 100U Injectable powder for solution 18,625,995 L.L
B02BD04 BENEFIX BioTech Nonacog alfa (recombinant coagulation factor IX) - 500IU 500IU Injectable powder for solution+diluent 27,390,281 L.L
L01FB01 BESPONSA FOR INJECTION BioTech Inotuzumab Ozogamicin - 0.9mg 0.9mg Injectable powder for suspension L.L
S01LA06 BEOVU BioTech Brolucizumab - 120mg/ml 120mg/ml Injectable solution L.L
L01FX07 BLINCYTO BioTech Blinatumomab - 35mcg 35mcg Injectable lyophilised powder for solution+stabilizer L.L
S01LA06 BEOVU BioTech Brolucizumab - 120mg/ml 120mg/ml Injectable solution 42,752,178 L.L
    3
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2026